@TaxesAreTheft I like Cellebrite a lot. The business model seems to have quite a moat. The increase in profits is not enormous, but it is already in the double-digit range. Free cash flow is also increasing. And the EbiT margin is around 14%, so there is still room for improvement. The KUV is unfortunately somewhat high, which is perhaps why the downward trend in the chart continues. It probably makes sense to wait for a change of direction and not to enter blindly now.
@TaxesAreTheft I can find virtually no multiples for d4t4 on Market Screener. Only the price chart doesn't look good. In this area I am in $INOD$EXLS$GFT etc. Invested
